Sensitive tumour detection and classification using plasma cell-free DNA methylomes
2018 · Nature · 974 citations
https://doi.org/10.1038/s41586-018-0703-0
A
Andrea Arruda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
183
Papers
3.7K
Citations
23
h-index
37
i10-index
Andrea Arruda is an academic researcher from University Health Network. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 23, co-authored 156 publications.
ORCID: 0000-0003-2516-8005Papers by this author
worksImmune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
2020 · Science Translational Medicine · 200 citations
https://doi.org/10.1126/scitranslmed.aaz0463
The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness
2022 · Nature Cell Biology · 82 citations
https://doi.org/10.1038/s41556-022-00925-9
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes
2018 · Blood Advances · 71 citations
https://doi.org/10.1182/bloodadvances.2018021469
CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission
2017 · Blood Cancer Journal · 45 citations
https://doi.org/10.1038/bcj.2017.52
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort
2022 · Leukemia · 8 citations
https://doi.org/10.1038/s41375-022-01544-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat